BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12682252)

  • 1. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
    Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
    J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.
    Roda-Navarro P; Vales-Gomez M; Chisholm SE; Reyburn HT
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11258-63. PubMed ID: 16849432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host immune system gene targeting by a viral miRNA.
    Stern-Ginossar N; Elefant N; Zimmermann A; Wolf DG; Saleh N; Biton M; Horwitz E; Prokocimer Z; Prichard M; Hahn G; Goldman-Wohl D; Greenfield C; Yagel S; Hengel H; Altuvia Y; Margalit H; Mandelboim O
    Science; 2007 Jul; 317(5836):376-81. PubMed ID: 17641203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding.
    Agüera-González S; Gross CC; Fernández-Messina L; Ashiru O; Esteso G; Hang HC; Reyburn HT; Long EO; Valés-Gómez M
    Eur J Immunol; 2011 Dec; 41(12):3667-76. PubMed ID: 21928280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D).
    Wang J; Nakafuku KM; Ziff J; Gelin CF; Gholami H; Thompson AA; Karpowich NK; Limon L; Coate HR; Damm-Ganamet KL; Shih AY; Grant JC; Côte M; Mak PA; Pascual HA; Rives ML; Edwards JP; Venable JD; Venkatesan H; Shi Z; Allen SJ; Sharma S; Kung PP; Shireman BT
    Bioorg Med Chem Lett; 2023 Nov; 96():129492. PubMed ID: 37778428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
    Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
    J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.
    Holdenrieder S; Stieber P; Peterfi A; Nagel D; Steinle A; Salih HR
    Cancer Immunol Immunother; 2006 Dec; 55(12):1584-9. PubMed ID: 16636811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors.
    Zhang C; Niu J; Zhang J; Wang Y; Zhou Z; Zhang J; Tian Z
    Cancer Sci; 2008 Jun; 99(6):1279-86. PubMed ID: 18422748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.
    Wu JD; Higgins LM; Steinle A; Cosman D; Haugk K; Plymate SR
    J Clin Invest; 2004 Aug; 114(4):560-8. PubMed ID: 15314693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.
    Jinushi M; Hodi FS; Dranoff G
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9190-5. PubMed ID: 16754847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis.
    Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z
    Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting NKG2D/NKG2DL axis in multiple myeloma therapy.
    Liu Z; Wang H; Liu H; Ding K; Shen H; Zhao X; Fu R
    Cytokine Growth Factor Rev; 2024 Apr; 76():1-11. PubMed ID: 38378397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.
    Pinto AK; Jamieson AM; Raulet DH; Hill AB
    J Virol; 2007 Nov; 81(22):12564-71. PubMed ID: 17855532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
    Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
    J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction.
    Nolting A; Dugast AS; Rihn S; Luteijn R; Carrington MF; Kane K; Jost S; Toth I; Nagami E; Faetkenheuer G; Hartmann P; Altfeld M; Alter G
    Virology; 2010 Oct; 406(1):12-20. PubMed ID: 20667578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matched sizes of activating and inhibitory receptor/ligand pairs are required for optimal signal integration by human natural killer cells.
    Köhler K; Xiong S; Brzostek J; Mehrabi M; Eissmann P; Harrison A; Cordoba SP; Oddos S; Miloserdov V; Gould K; Burroughs NJ; van der Merwe PA; Davis DM
    PLoS One; 2010 Nov; 5(11):e15374. PubMed ID: 21179506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion.
    Wang R; Natarajan K; Revilleza MJ; Boyd LF; Zhi L; Zhao H; Robinson H; Margulies DH
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):E3578-87. PubMed ID: 23169621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation.
    Petersdorf EW; McKallor C; Malkki M; He M; Spellman SR; Hsu KC; Strong RK; Gooley T; Stevenson P
    Blood Adv; 2023 Jun; 7(12):2888-2896. PubMed ID: 36763517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells.
    Weiss-Steider B; Soto-Cruz I; Martinez-Campos CA; Mendoza-Rincon JF
    J Exp Clin Cancer Res; 2011 Apr; 30(1):37. PubMed ID: 21477352
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Aguilar OA; Qualls AE; Gonzalez-Hinojosa MDR; Obeidalla S; Kerchberger VE; Tsao T; Singer JP; Looney MR; Raymond W; Hays SR; Golden JA; Kukreja J; Shaver CM; Ware LB; Christie J; Diamond JM; Lanier LL; Greenland JR; Calabrese DR
    Am J Respir Crit Care Med; 2024 Jan; 209(1):70-82. PubMed ID: 37878820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.